Skip to Main Content

An official website of the United States government

Here you can browse the complete list of publications for studies listed on CDAS.

Publication Year
Results: 1530 (Showing 1 to 20)
Title PubMed Authors Journal Year Studies
Comparing Lung Cancer Screening Strategies in a Nationally Representative US Population Using Transportability Methods for the National Lung Cancer Screening Trial. 38289605 Robertson SE, Joyce NR, Steingrimsson JA, Stuart EA, Aberle DR, Gatsonis CA, Dahabreh IJ JAMA Netw Open 2024 NLST
Long-term Survival After Lung Cancer Resection in the National Lung Screening Trial. 38216080 Potter AL, Senthil P, Keshwani A, McCleery S, Haridas C, Kumar A, Mathey-Andrews C, Martin LW, Yang CJ Ann Thorac Surg 2024 NLST
Enrichment of lung cancer computed tomography collections with AI-derived annotations. 38177130 Krishnaswamy D, Bontempi D, Thiriveedhi VK, Punzo D, Clunie D, Bridge CP, Aerts HJWL, Kikinis R, Fedorov A Sci Data 2024 NLST
A randomized Phase I pre-operative window trial of transdermal endoxifen in women planning mastectomy: Evaluation of dermal safety, intra-mammary drug distribution, and biologic effects. 38171245 Lee O , Bazzi LA , Xu Y , Pearson E , Wang M , Hosseini O , Akasha AM , Choi JN , Karlan S , Pilewskie M , Kocherginsky M , Benante K , Helland T , Mellgren G , Dimond E , Perloff M , Heckman-Stoddard BM , Khan SA Biomed Pharmacother 2024 EPPT
Contributions of the Microbiome-Derived Metabolome for Risk Assessment and Prognostication of Pancreatic Cancer. 38175578 León-Letelier RA, Dou R, Vykoukal J, Yip-Schneider MT, Maitra A, Irajizad E, Wu R, Dennison JB, Do KA, Zhang J, Schmidt CM, Hanash S, Fahrmann JF Clin Chem 2024 PLCO
Helicobacter hepaticus and Helicobacter bilis in liver and biliary cancers from ATBC and PLCO. 38332674 Murphy G, Freedman ND, Abnet CC, Albanes D, Cross AJ, Huang WY, Koshiol J, McGlynn K, Parisi D, Männistö S, Weinstein SJ, Waterboer T, Butt J Helicobacter 2024 PLCO
Associations of serum trimethylamine N-oxide and its precursors with colorectal cancer risk in the Prostate, Lung, Colorectal, Ovarian Cancer Screening Trial Cohort. 38285606 Byrd DA , Zouiouich S , Karwa S , Li XS , Wang Z , Sampson JN , Loftfield E , Huang WY , Hazen SL , Sinha R Cancer 2024 PLCO
Polymorphisms in transcription factor binding sites and enhancer regions and pancreatic ductal adenocarcinoma risk. 38308339 Ünal P, Lu Y, Bueno-de-Mesquita B, van Eijck CHJ, Talar-Wojnarowska R, Szentesi A, Gazouli M, Kreivenaite E, Tavano F, Małecka-Wojciesko E, Erőss B, Oliverius M, Bunduc S, Nóbrega Aoki M, Vodickova L, Boggi U, Giaccherini M, Kondrackiene J, Chammas … Hum Genomics 2024 PLCO
Evidence for a causal link between intra-pancreatic fat deposition and pancreatic cancer: A prospective cohort and Mendelian randomization study. 38280379 Yamazaki H, Streicher SA, Wu L, Fukuhara S, Wagner R, Heni M, Grossman SR, Lenz HJ, Setiawan VW, Le Marchand L, Huang BZ Cell Rep Med 2024 PLCO
Elucidating the role of blood metabolites on pancreatic cancer risk using two-sample Mendelian randomization analysis. 37860916 Zhong H, Liu S, Zhu J, Xu TH, Yu H, Wu L Int J Cancer 2024 PLCO
Regulome-wide association study identifies genetically driven accessible regions associated with pancreatic cancer risk. 37850323 Liu S, Zhong H, Zhu J, Wu Y, Deng Y, Wu L Int J Cancer 2024 PLCO
Penalized deep partially linear cox models with application to CT scans of lung cancer patients. 38412302 Sun Y, Kang J, Haridas C, Mayne N, Potter A, Yang CF, Christiani DC, Li Y Biometrics 2024 NLST
Body size and risk of colorectal cancer molecular defined subtypes and pathways: Mendelian randomization analyses. 38350331 Papadimitriou N, Qu C, Harrison TA, Bever AM, Martin RM, Tsilidis KK, Newcomb PA, Thibodeau SN, Newton CC, Um CY, Obón-Santacana M, Moreno V, Brenner H, Mandic M, Chang-Claude J, Hoffmeister M, Pellatt AJ, Schoen RE, Harlid S, Ogino S, Ugai T, Bucha… EBioMedicine 2024 PLCO
Epidemiologic factors in relation to colorectal cancer risk and survival by genotoxic colibactin mutational signature. 38252034 Thomas CE, Georgeson P, Qu C, Steinfelder RS, Buchanan DD, Song M, Harrison TA, Um CY, Hullar MA, Jenkins MA, Van Guelpen B, Lynch BM, Melaku YA, Huyghe JR, Aglago EK, Berndt SI, Boardman LA, Campbell PT, Cao Y, Chan AT, Drew DA, Figueiredo JC, Fren… Cancer Epidemiol Biomarkers Prev 2024 PLCO
Genotoxic colibactin mutational signature in colorectal cancer is associated with clinicopathological features, specific genomic alterations and better survival. 37090539 Georgeson P, Steinfelder RS, Harrison TA, Pope BJ, Zaidi SH, Qu C, Lin Y, Joo JE, Mahmood K, Clendenning M, Walker R, Aglago EK, Berndt SI, Brenner H, Campbell PT, Cao Y, Chan AT, Chang-Claude J, Dimou N, Doheny KF, Drew DA, Figueiredo JC, French AJ… medRxiv 2024 PLCO
Doubly robust estimation of optimal treatment regimes for survival data using an instrumental variable. Junwen, X., Zishu, Z. & Jingxiao, Z. Stat Comput 2024 PLCO
OWL: an optimized and independently validated machine learning prediction model for lung cancer screening based on the UK Biobank, PLCO, and NLST populations. 36701900 Pan Z, Zhang R, Shen S, Lin Y, Zhang L, Wang X, Ye Q, Wang X, Chen J, Zhao Y, Christiani DC, Li Y, Chen F, Wei Y EBioMedicine 2023 NLST, PLCO
Risk prediction models for endometrial cancer: development and validation in an international consortium. 36688725 Shi J, Kraft P, Rosner B, Benavente Y, Black A, Brinton LA, Chen C, Clarke MA, Cook LS, Costas L, Dal Maso L, Freudenheim JL, Frias-Gomez J, Friedenreich CM, Garcia-Closas M, Goodman MT, Johnson L, La Vecchia C, Levi F, Lissowska J, Lu L, McCann SE,… J Natl Cancer Inst 2023 PLCO
GWAS Explorer: an open-source tool to explore, visualize, and access GWAS summary statistics in the PLCO Atlas. 36635305 Machiela MJ, Huang WY, Wong W, Berndt SI, Sampson J, De Almeida J, Abubakar M, Hislop J, Chen KL, Dagnall C, Diaz-Mayoral N, Ferrell M, Furr M, Gonzalez A, Hicks B, Hubbard AK, Hutchinson A, Jiang K, Jones K, Liu J, Loftfield E, Loukissas J, Mabie J… Sci Data 2023 PLCO
Sybil: A Validated Deep Learning Model to Predict Future Lung Cancer Risk From a Single Low-Dose Chest Computed Tomography. 36634294 Mikhael PG, Wohlwend J, Yala A, Karstens L, Xiang J, Takigami AK, Bourgouin PP, Chan P, Mrah S, Amayri W, Juan YH, Yang CT, Wan YL, Lin G, Sequist LV, Fintelmann FJ, Barzilay R J Clin Oncol 2023 NLST